Recombinant porcine pseudorabies virus for expressing GP protein of porcine reproductive and respiratory syndrome virus, and application
A technology for porcine pseudorabies and respiratory syndrome, applied in the direction of viruses, antiviral agents, virus antigen components, etc., can solve the problems of serious harm and lack of prevention and control measures, and achieve strong pertinence, strong immune protection effect, and comprehensive antigen types. Effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0036] Example 1 Construction of recombinant porcine pseudorabies virus expressing porcine reproductive and respiratory syndrome virus GP protein
[0037] The present invention utilizes the advantages of the Crispr / Cas9 gene editing system and the Cre / lox recombinase system to quickly edit the viral genome, deletes the PRV SDN8 virulence genes TK, gI and gE, and uses the gene-deleted strain as a carrier, and in its gG gene Insert the antigen gene of PRRSV NADC30-like (including the non-transmembrane region coding sequence of GP3, GP4, GP5 and GP6 proteins), and develop live vaccines based on the GP gene of porcine pseudorabies virus recombinant porcine PRRS virus.
[0038] 1. sgRNA sequence design and recombinant vector construction
[0039] According to the TK, gE, gI and gG virulence gene sequences, online (http: / / crispr.mit.edu / ) design the single guide RNA (sgRNA) sequence targeting the deletion sequence, synthesize single-stranded DNA primers, anneal and ligate and trans...
Embodiment 2
[0061] Embodiment 2 recombinant porcine pseudorabies virus PRV SDN8-TK - / gE - / gI - / gG - -GP + Safety Tests on Mice
[0062] Purchase 30 6-8 week-old Kunming mice (gB, gE antibody and GP5 antibody are negative), randomly divided into A, B, C 3 groups, A group back subcutaneously injected 10 6 TCID 50 PRV SDN8-TK - / gE - / gI - / gG - -GP + Recombinant virus; group B back subcutaneously injected 10 6 TCID 50 For the PRV JS2012 wild-type strain, about an equal volume of serum-free DMEM medium was subcutaneously injected into the back of group C. Continuous observation for 7 days.
[0063] The results showed that the mice in groups A and C had no disease, and their spirit and appetite were good; the mice in group B all died on the third day after injection. Indicating that PRV SDN8-TK - / gE- / gI- / gG - -GP + The safety of the recombinant virus is good and can be used as a live vaccine.
Embodiment 3
[0064] Embodiment 3 recombinant porcine pseudorabies virus PRV SDN8-TK - / gE - / gI - / gG - -GP + Immunogenicity test on piglets
[0065] Select 20 21-day-old pseudorabies and PRRS-negative piglets (negative for gB, gE and GP5 antibodies), and randomly divide them into groups A, B, C and D, with 5 piglets in each group, and keep them in isolation. Intramuscular injection of PRV SDN8-TK in groups A and B - / gE - / gI - / gG - -GP + Strains (1.0×10 6.0 TCID 50 per head), C and D groups were injected with 1mL DMEM as unimmunized control. Piglets did not have any clinical symptoms after immunization. On the 21st day after immunization, blood was collected from the anterior vena cava in all four groups. Anti-gB ELISA (purchased from IDEXX Company) was used to detect gB antibody levels in groups A and C, and anti-GP5 ELISA (purchased from IDEXX Company) was used in groups B and D. Detect the level of GP5 antibody; and use PRVJS2012 strain and PRRSV NADC30-like strain to co...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com